Health

Kamada to Announce Fiscal Year and Fourth Quarter 2025 Financial Results on March 11, 2026

Company to Host Conference Call at 8:30am ET March 04, 2026 07:00 ET  | Source: Kamada Ltd. REHOVOT, Israel, and…

4 months ago

Persevere Therapeutics Launches as a Clinical-Stage Oncology Company with a Novel Phase 1b/2a Agent and Announces First Close of Seed Financing

Chesterbrook, PA, March 03, 2026 (GLOBE NEWSWIRE) -- Persevere Therapeutics, Inc. (“Persevere”), a Delaware-incorporated, clinical-stage oncology biotechnology company, today announced…

4 months ago

Inteleos 2026 Leadership Elections Accelerate Vision for Global Healthcare

ROCKVILLE, Md., March 03, 2026 (GLOBE NEWSWIRE) -- Inteleos today announced its 2026 leadership elections that build on more than…

4 months ago

Psyence BioMed Announces Export of GMP-Manufactured Natural Psilocybin (NPX-5) to Australia for Ongoing Phase IIb Clinical Trial

NEW YORK, March 03, 2026 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence BioMed” or the “Company”), a biopharmaceutical…

4 months ago

RadNet, Inc. to Present at the Raymond James 47th Annual Institutional Investors Conference on Tuesday, March 3rd, 2026

March 02, 2026 13:16 ET  | Source: RadNet, Inc. LOS ANGELES, March 02, 2026 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ:…

4 months ago

Smith+Nephew to feature leading rotator cuff repair portfolio including new Tendon Seam Repair System and REGENETEN Bioinductive Implant at AAOS 2026

Uniting the most advanced technologies for biomechanical repair and biological augmentation  Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today…

4 months ago

Pediatric Home Service Partners with Morgans to Expand Prescribed Pediatric Extended Care Services in Texas with New Center, Morgans Wonder Care

SAN ANTONIO, March 02, 2026 (GLOBE NEWSWIRE) -- Pediatric Home Service (PHS), a national provider of comprehensive pediatric healthcare, is…

4 months ago

Investor Education Webinar

The Future of Prostate Imaging: What do physicians want? March 01, 2026 17:57 ET  | Source: Telix Pharmaceuticals Limited MELBOURNE,…

4 months ago

Rhythm Pharmaceuticals Announces Additional Positive Data from Phase 3 TRANSCEND trial of Setmelanotide in Patients with Acquired Hypothalamic Obesity

-- -18.8% placebo-adjusted difference in BMI reduction achieved in all patients (N=142) at 52 weeks, including 12 Japanese patients and…

4 months ago